Feasibility study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage H-IHA non-small cell lung cancer

被引：0
|
作者：
Yoshimura, N. [1 ]
Kudoh, S. [1 ]
Mitsuoka, S. [1 ]
Kimura, T. [1 ]
Hirata, K. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka 558, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e17514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17514
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN IN PATIENTS WITH COMPLETELY RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER
    FELD, R
    RUBINSTEIN, L
    THOMAS, PA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04): : 299 - 306
  • [42] Gemcitabine/vinorelbine/cisplatin in patients with advanced non-small cell lung cancer
    Doweik, L
    Pohl, G
    Malayeri, R
    Krajnik, G
    Minar, W
    Pirker, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 263 - 266
  • [43] Evaluation of the Safety and Compliance of 3-Week Cycles of Vinorelbine on Days 1 and 8 and Cisplatin on Day 1 as Adjuvant Chemotherapy in Japanese Patients with Completely Resected Pathological Stage IB to IIIA Non-small Cell Lung Cancer: A Retrospective Study
    Shukuya, Takehito
    Takahashi, Toshiaki
    Tamiya, Akihiro
    Ono, Akira
    Igawa, Satoshi
    Tsuya, Asuka
    Nakamura, Yukiko
    Murakami, Haruyasu
    Naito, Tateaki
    Kaira, Kyoichi
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (03) : 158 - 162
  • [44] VALIDATION STUDY OF POSTOPERATIVE PLATINUM-BASED ADJUVANT CHEMOTHERAPY FOR JAPANESE PATIENTS WITH COMPLETELY RESECTED PATHOLOGICAL STAGEIIIA NON-SMALL CELL LUNG CANCER
    Shiomi, Kazu
    Takakura, Noriyuki
    Ryuge, Shinichiro
    Hayashi, Syoko
    Ishii, Dai
    Yamazaki, Hirotsugu
    Naito, Masahito
    Matsui, Yoshio
    Mikubo, Masashi
    Ogawa, Fumihiro
    Sasaki, Jiichiro
    Nakashima, Hiroyasu
    Masuda, Noriyuki
    Satoh, Yukitoshi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S585 - S585
  • [45] Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
    Lee, Kuan-Yu
    Hsu, Chen-Xiong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 647 - 648
  • [46] Is adjuvant radiochemotherapy superior to postoperative radiotherapy alone in patients with completely resected stage II or IIIA non-small cell lung cancer?
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (04) : 220 - 221
  • [47] Substantial risk affects the stage-dependent outcomes of cisplatin-based adjuvant chemotherapy for completely resected non-small cell lung cancer
    Yoshino, Ichiro
    SURGERY TODAY, 2014, 44 (02) : 302 - 306
  • [48] Substantial risk affects the stage-dependent outcomes of cisplatin-based adjuvant chemotherapy for completely resected non-small cell lung cancer
    Ichiro Yoshino
    Surgery Today, 2014, 44 : 302 - 306
  • [49] Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    De Marchi, Pedro
    Goto, Yasushi
    Kowalski, Dariusz
    Lu, Shun
    Spigel, David R.
    Thomas, Michael
    Yang, James Chih-Hsin
    Turri, Sabine
    Zhou, Wen
    Kreisl, Teri
    Paz-Ares, Luis
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [50] PhaseIIstudy of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non-small cell lung cancer
    Tachihara, Motoko
    Dokuni, Ryota
    Okuno, Keiko
    Tokunaga, Shuntaro
    Nakata, Kyosuke
    Katsurada, Naoko
    Yamamoto, Masatsugu
    Nagano, Tatsuya
    Kobayashi, Kazuyuki
    Tanaka, Yugo
    Funada, Yasuhiro
    Maniwa, Yoshimasa
    Nishimura, Yoshihiro
    THORACIC CANCER, 2020, 11 (09) : 2536 - 2541
12345